Infant Bacterial Therapeutics AB (publ) 9IB.SG Stock
Infant Bacterial Therapeutics AB (publ) Price Chart
Infant Bacterial Therapeutics AB (publ) 9IB.SG Financial and Trading Overview
Contents
| Infant Bacterial Therapeutics AB (publ) stock price | 6.94 EUR |
| Previous Close | 3.78 EUR |
| Open | 3.78 EUR |
| Bid | 3.75 EUR x 0 |
| Ask | 3.99 EUR x 0 |
| Day's Range | 3.74 - 3.78 EUR |
| 52 Week Range | 3.59 - 6.53 EUR |
| Volume | 0 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 44.48M EUR |
| Beta (5Y Monthly) | 1.059003 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.86 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
9IB.SG Valuation Measures
| Enterprise Value | 70.84M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.64194983 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Infant Bacterial Therapeutics AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.059003 |
| 52-Week Change | -28.78% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.53 EUR |
| 52 Week Low | 3.59 EUR |
| 50-Day Moving Average | 3.96 EUR |
| 200-Day Moving Average | 4.65 EUR |
9IB.SG Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 10.85M |
| Float | 9.91M |
| Short Ratio | N/A |
| % Held by Insiders | 8.15% |
| % Held by Institutions | 30.17% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -11.94% |
| Return on Equity (ttm) | -20.054% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.54 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 13.22 |
| Book Value Per Share (mrq) | 5.826 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Infant Bacterial Therapeutics AB (publ)
| Country | Germany |
| State | N/A |
| City | Stockholm |
| Address | Bryggargatan 10 |
| ZIP | 111 21 |
| Phone | 46 7 62 19 37 38 |
| Website | https://www.ibtherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Infant Bacterial Therapeutics AB (publ), a clinical stage pharmaceutical company, develops drugs to prevent or treat rare diseases affecting premature infants in Sweden. The company's lead drug candidate is IBP-9414, to prevent necrotizing enterocolitis, as well as to improve feeding tolerance affecting premature infants. It is also developing IBP-1016 for the treatment of gastroschisis, a rare and severe disease in infants. The company was incorporated in 2011 and is based in Stockholm, Sweden.
Q&A For Infant Bacterial Therapeutics AB (publ) Stock
What is a current 9IB.SG stock price?
Infant Bacterial Therapeutics AB (publ) 9IB.SG stock price today per share is 6.94 EUR.
How to purchase Infant Bacterial Therapeutics AB (publ) stock?
You can buy 9IB.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Infant Bacterial Therapeutics AB (publ)?
The stock symbol or ticker of Infant Bacterial Therapeutics AB (publ) is 9IB.SG.
Which industry does the Infant Bacterial Therapeutics AB (publ) company belong to?
The Infant Bacterial Therapeutics AB (publ) industry is Biotechnology.
How many shares does Infant Bacterial Therapeutics AB (publ) have in circulation?
The max supply of Infant Bacterial Therapeutics AB (publ) shares is 14M.
What is Infant Bacterial Therapeutics AB (publ) Price to Earnings Ratio (PE Ratio)?
Infant Bacterial Therapeutics AB (publ) PE Ratio is now.
What was Infant Bacterial Therapeutics AB (publ) earnings per share over the trailing 12 months (TTM)?
Infant Bacterial Therapeutics AB (publ) EPS is -0.86 EUR over the trailing 12 months.
Which sector does the Infant Bacterial Therapeutics AB (publ) company belong to?
The Infant Bacterial Therapeutics AB (publ) sector is Healthcare.